There were 1,430 press releases posted in the last 24 hours and 430,551 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
U.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image